Search Results - "Krebs, Michael R."

Sex differences in ectopic lipid deposits and cardiac function across a wide range of glycemic control: a secondary analysis by Harreiter, Jürgen, Just, Ivica, Weber, Michael, Klepochová, Radka, Bastian, Magdalena, Winhofer, Yvonne, Wolf, Peter, Scherer, Thomas, Leutner, Michael, Kosi‐Trebotic, Lana, Deischinger, Carola, Chmelík, Marek, Krebs, Michael R., Trattnig, Siegfried, Krššák, Martin, Kautzky‐Willer, Alexandra

“…The objective of this study was to identify sex differences in ntrahepatocellular (HCL) and intramyocardial lipids (MYCL) and cardiac function in participants…”
Get full text

Switch to Combined GLP1 Receptor Agonist Lixisenatide with Basal Insulin Glargine in Poorly Controlled T2DM Patients with Premixed Insulin Therapy: A Clinical Observation and Pilot Study in Nine Patients by Harreiter, Jürgen, Kosi-Trebotic, Lana, Lukas, Albert, Wolf, Peter, Winhofer, Yvonne, Luger, Anton, Kautzky-Willer, Alexandra, Krebs, Michael R.

“…Introduction To prove the feasibility and safety of a conversion to once-daily injected GLP1 agonist (lixisenatide) and long-acting basal insulin analogue…”
Get full text

Plasma proteomic signatures of a direct measure of insulin sensitivity in two population cohorts by Zanetti, Daniela, Stell, Laurel, Gustafsson, Stefan, Abbasi, Fahim, Tsao, Philip S., Knowles, Joshua W., Zethelius, Björn, Ärnlöv, Johan, Balkau, Beverley, Walker, Mark, Lazzeroni, Laura C., Lind, Lars, Petrie, John R., Assimes, Themistocles L.

“…Aims/hypothesis The euglycaemic–hyperinsulinaemic clamp (EIC) is the reference standard for the measurement of whole-body insulin sensitivity but is laborious…”
Get full text